Nalu Medical
Private Company
Total funding raised: $120M
Overview
Nalu Medical is a clinical-stage medical device company pioneering a novel, miniaturized neurostimulation system for chronic pain management. Its core innovation is a non-integrated, battery-free microstimulator that is significantly smaller than traditional implantable pulse generators (IPGs), aiming to reduce surgical burden and offer greater patient flexibility. The company has a commercially focused product and is led by an experienced management team with deep roots in major medtech firms. Nalu operates in the large and growing chronic pain market, competing against established neuromodulation players with a potentially disruptive form factor and upgrade path.
Technology Platform
A miniaturized, non-integrated, battery-free neurostimulation system consisting of an implanted micro-stimulator, a separate electrode array, and an externally worn, upgradeable Therapy Disc that powers the implant wirelessly.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Nalu competes in the neuromodulation for pain market against large, established players like Medtronic, Boston Scientific, Abbott, and Nevro, who market traditional implantable pulse generators (IPGs). Nalu's primary competitive differentiation is its drastically smaller size, battery-free design, and upgradable external component, which together aim to reduce surgical burden and future-proof the therapy.